Pharma Journalist -

Novartis and Molecular Partners announced that Part A of the EMPATHY clinical trial1 that compared single intravenous doses of ensovibep, a DARPin antiviral therapeutic candidate vs.…
Read More...

Bayer AG and Mammoth Biosciences, Inc., which is harnessing the diversity of nature to power the next-generation CRISPR products, announced a strategic collaboration and option…
Read More...

Pfizer Inc. and Acuitas Therapeutics, a company focused on developing lipid nanoparticle (LNP) delivery systems to enable messenger RNA (mRNA)-based therapeutics, announced they have…
Read More...

Century Therapeutics and Bristol Myers Squibb announced today a research collaboration and license agreement (the “agreement”) to develop and commercialize up to four induced…
Read More...

SMi Group reports: exclusive speaker interview with microbiology expert Karen Capper, AstraZeneca about the developments in the microbiology field. Now in its 10th Annual year, the…
Read More...

Johnson & Johnson announced new results from the largest study to date on the durability of COVID-19 vaccines in the United States (U.S.), showing that a single shot of the Johnson…
Read More...

Amgen and Generate Biomedicines announced a research collaboration agreement to discover and create protein therapeutics for five clinical targets across several therapeutic areas and…
Read More...

TRexBio Inc., a discovery stage company decoding tissue immune biology to create revolutionary therapeutics, announced that it has entered into a multi-year research collaboration and…
Read More...

SMi Reports: Event Announcement: Transdermal and Microneedle Drug Delivery, January 12-13th January 2021 is now 3weeks away and is a virtual event. Access will be fully online…
Read More...

In the run up to our series of 2022 Pre-filled Syringes and Injectable Drug Delivery group of conferences taking place worldwide over the course of 2022, we at SMi undertook a survey…
Read More...